CUSIP 25253X207COM NEWDMACQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
92 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Cooperman Leon G | 2.02M | $16.08M | −1.25M | Reduced |
| 2 | Blackrock, Inc. | 1.90M | $15.13M | +222.8K | Added |
| 3 | Paragon Associates & Paragon Associates II Joint Venture | 875.0K | $6.96M | 0 | Held |
| 4 | Millennium Management LLC | 768.6K | $6.12M |
| −418.7K |
| Reduced |
| 5 | Geode Capital Management, LLC | 764.3K | $6.08M | +52.4K | Added |
| 6 | Vanguard Group Inc | 723.1K | $5.76M | +58.5K | Added |
| 7 | State Street Corp | 627.8K | $5.00M | +151.2K | Added |
| 8 | Morgan Stanley | 547.6K | $4.36M | −32.0K | Reduced |
| 9 | First Manhattan Co. LLC. | 405.0K | $3.22M | −100.0K | Reduced |
| 10 | Bleichroeder LP | 382.3K | $3.04M | 0 | Held |
See every fund holding Diamedica Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders